121 related articles for article (PubMed ID: 24011601)
1. [Induction chemotherapy for locally advanced head and neck cancer].
Calais G; Chapet S; Ruffier-Loubière A; Bernadou G
Cancer Radiother; 2013 Oct; 17(5-6):498-501. PubMed ID: 24011601
[TBL] [Abstract][Full Text] [Related]
2. [Observance and results of concurrent chemoradiotherapy after induction chemotherapy by docetaxel, cisplatin and 5-fluoro-uracil for locally advanced head and neck cancers].
Calderon B; Guerder C; Resbeut M; Fakhry N; Dupuis C; Cowen D
Cancer Radiother; 2016 Apr; 20(2):83-90. PubMed ID: 26969244
[TBL] [Abstract][Full Text] [Related]
3. Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?
Paccagnella A; Mastromauro C; D'Amanzo P; Ghi MG
Oncologist; 2010; 15 Suppl 3():8-12. PubMed ID: 21036883
[TBL] [Abstract][Full Text] [Related]
4. Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.
Tishler RB; Posner MR; Norris CM; Mahadevan A; Sullivan C; Goguen L; Wirth LJ; Costello R; Case M; Stowell S; Sammartino D; Busse PM; Haddad RI
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1036-44. PubMed ID: 16682134
[TBL] [Abstract][Full Text] [Related]
5. [Role and interest of induction chemotherapy for head and neck cancers].
Pointreau Y; Schick U; Huguet F
Cancer Radiother; 2017 Oct; 21(6-7):505-509. PubMed ID: 28865969
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy for head and neck cancer: recent data.
Vokes EE
Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882
[TBL] [Abstract][Full Text] [Related]
7. Current status and future directions in induction chemotherapy for head and neck cancer.
Argiris A
Crit Rev Oncol Hematol; 2013 Oct; 88(1):57-74. PubMed ID: 23541071
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel in the management of patients with head and neck squamous cell carcinoma.
Bernier J; Vrieling C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1023-32. PubMed ID: 18588449
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
11. [Role of induction chemotherapy in head and neck cancer: Cons].
Huguet F; Schick U; Pointreau Y
Cancer Radiother; 2017 Oct; 21(6-7):510-514. PubMed ID: 28869196
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy for squamous cell head and neck cancer: a neverending story?
Benasso M
Oral Oncol; 2013 Aug; 49(8):747-52. PubMed ID: 23683948
[TBL] [Abstract][Full Text] [Related]
13. The role of chemotherapy in locally advanced head and neck squamous cell carcinoma.
Nwizu T; Ghi MG; Cohen EE; Paccagnella A
Semin Radiat Oncol; 2012 Jul; 22(3):198-206. PubMed ID: 22687944
[TBL] [Abstract][Full Text] [Related]
14. [Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy].
Bardet E; Bourhis J; Cals L; Fayette J; Guigay J; Hans S; Saint-Guily JL; Lagarde F; Lallemant B; Milano G; Rolland F; Lefebvre JL
Bull Cancer; 2009 Oct; 96(10):1013-28. PubMed ID: 19744919
[TBL] [Abstract][Full Text] [Related]
15. TPF: a rational choice for larynx preservation?
Calais G
Oncologist; 2010; 15 Suppl 3():19-24. PubMed ID: 21036885
[TBL] [Abstract][Full Text] [Related]
16. Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.
Haddad RI; Wirth L; Posner MR
Expert Rev Anticancer Ther; 2003 Jun; 3(3):331-8. PubMed ID: 12820776
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of induction chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil followed by concurrent radiotherapy with cetuximab in locally advanced head and neck cancer.
Kim B; Dillman RO; Chen P; Hafer R; Cox C; Barth N; Carroll RM; VanderMolen L; Nguyen M; Huang J; Minion A; Plunkett M; Mackintosh R
Am J Otolaryngol; 2012; 33(1):93-7. PubMed ID: 21524816
[TBL] [Abstract][Full Text] [Related]
18. Functional organ preservation in locally advanced laryngeal squamous cell carcinoma: is there a role for induction chemotherapy?
Loo SW; Geropantas K; Roques TW
Clin Oncol (R Coll Radiol); 2013 May; 25(5):298-307. PubMed ID: 23290343
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy in locally advanced head and neck cancer: a new standard of care?
Lorch JH; Posner MR; Wirth LJ; Haddad RI
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1155-63, viii. PubMed ID: 19010265
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
Posner MR; Hershock DM; Blajman CR; Mickiewicz E; Winquist E; Gorbounova V; Tjulandin S; Shin DM; Cullen K; Ervin TJ; Murphy BA; Raez LE; Cohen RB; Spaulding M; Tishler RB; Roth B; Viroglio Rdel C; Venkatesan V; Romanov I; Agarwala S; Harter KW; Dugan M; Cmelak A; Markoe AM; Read PW; Steinbrenner L; Colevas AD; Norris CM; Haddad RI;
N Engl J Med; 2007 Oct; 357(17):1705-15. PubMed ID: 17960013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
